Atenolol is a selective ?1 receptor antagonist, a drug belonging to the group of beta blockers (sometimes written ?-blockers), a class of drugs used primarily in cardiovascular diseases. Introduced in 1976, atenolol was developed as a replacement for propranolol in the treatment of hypertension. It works by slowing down the heart and reducing its workload. Unlike propranolol, atenolol does not readily pass through the blood-brain barrier, thus decreasing the incidence of central nervous system side effects.

Atenolol is one of the most widely used ?-blockers in the United Kingdom and was once the first-line treatment for hypertension. However, recent studies indicate that atenolol may not reduce morbidity or mortality when used to treat hypertension, and may even increase mortality in some subgroups. In addition, the role for ?-blockers in general in hypertension was downgraded in June 2006 in the United Kingdom, and later in the United States, as they are less appropriate than newer drugs, particularly in the elderly.

Complete Report Available @ http://www.radiantinsights.com/research/global-atenolol-market-outlook-2016-2021

This report provides detailed analysis of worldwide markets for Atenolol from 2011-2015 and provides extensive market forecasts 2016-2021 by region/country and subsectors. It covers the key technological and market trends in the Atenolol market and further lays out an analysis of the factors influencing the supply/demand for Atenolol, and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.

Request a Sample Copy of This Report @ http://www.radiantinsights.com/research/global-atenolol-market-outlook-2016-2021/request-sample

The report has been prepared based on the synthesis, analysis, and interpretation of information about the global Atenolol market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Atenolol market are KOPRAN (India), AMRI India (India), Ipca Laboratories (India), Ipca (India), CFM Group (Italy), Teva (Israel), Chifeng Arker (China), among others.

The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Atenolol industry has been provided.

See More Reports of This Category by Radiant Insights @ http://www.radiantinsights.com/catalog/pharmaceutical

About Radiant Insights,Inc
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

Media Contact:
Michelle Thoras
201 Spear Street 1100,
Suite 3036, San Francisco,
CA 94105, United States
Tel: 1-415-349-0054
Toll Free: 1-888-928-9744
Mail: [email protected]